Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
0.9731
-0.0569 (-5.52%)
Oct 23, 2026, 12:17 PM EDT - Market open
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $125.21 million as of October 23, 2026. It is the 23,273rd most valuable company in the world and the 3,888th biggest in the United States. Its market cap has decreased by 75.81% in one year.
Market Cap
125.21M
Enterprise Value
146.07M
1-Year Change
-75.81%
Global Rank
Country Rank
#3,888 United States
Category
ChartMarket Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $125.21M, a decrease of -89.87%. That is a compound annual growth rate of -25.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 127.56M | -80.60% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lifecore Biomedical | 241.12M |
| SIGA Technologies | 226.33M |
| Glass House Brands | 214.87M |
| ADC Therapeutics | 204.27M |
| Akebia Therapeutics | 155.79M |
| Journey Medical | 143.66M |
| Cardiol Therapeutics | 136.51M |
| Organigram Global | 130.61M |